Numéros de Téléphone Daud Daniele
Safety and Tumor Responses with â¦
02/06/2013 · Original Article. Safety and Tumor Responses with Lambrolizumab (AntiâPD-1) in Melanoma. Omid Hamid, M.D., Caroline Robert, M.D., Ph.D., Adil Daudâ¦
http://www.nejm.org/doi/full/10.1056/nejmoa1305133
Combined BRAF and MEK Inhibition in â¦
Original Article. Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations. Keith T. Flaherty, M.D., Jeffery R. Infante, M.D., Adil Daud, M.D., Rene ...
http://www.nejm.org/doi/full/10.1056/NEJMoa1210093